marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Fate Therapeutics Cash Flow 2011-2024 | FATE
Annual Cash Flow Fate Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-132 M | -248 M | -163 M | -39.2 M | -83.2 M | -38.6 M | -36.8 M | -29.8 M | - | - | - | - | - |
Depreciation & Amortization |
18.3 M | 13.8 M | 5.85 M | 3.09 M | 2.19 M | 1.2 M | 971 K | 881 K | 687 K | 496 K | 571 K | 590 K | 672 K |
Accounts Payables |
4.72 M | 8.26 M | 8.61 M | 6.28 M | 5.82 M | 4.2 M | 1.68 M | 934 K | 996 K | 645 K | 682 K | - | - |
Accounts Receivables |
1.83 M | 38.5 M | 8.68 M | 5.52 M | - | 500 K | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Fate Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | -28.9 M | - | -173 M | - | -64.6 M | - | -92.6 M | - | -27.1 M | - | -18.6 M | 12.2 M | -26.7 M | - | -57.6 M | -37.8 M | -17.5 M | - | -27.6 M | -24.1 M | -12.6 M | - | -26.1 M | -16.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | 4.19 M | - | 8.92 M | - | 2.76 M | - | 3.64 M | - | 959 K | - | 2.23 M | 1.45 M | 705 K | - | 1.57 M | 983 K | 440 K | - | 877 K | 567 K | 286 K | - | 681 K | 437 K | 206 K | - | 678 K | 460 K | 227 K | - | 477 K | 290 K | 128 K | - | 371 K | 256 K | 123 K | - | 442 K | 302 K | 157 K | - | 430 K | - | - | - | - | - | - |
Accounts Payables |
6.35 M | 5.5 M | 4.72 M | 5.71 M | 7.51 M | 9.86 M | 8.26 M | 9.59 M | - | 11.4 M | 8.61 M | 6.44 M | 5.77 M | 9 M | 6.28 M | 6.28 M | 6.28 M | 6.28 M | 5.82 M | 5.82 M | 5.82 M | 5.82 M | 4.2 M | 4.2 M | 4.2 M | 4.2 M | 1.68 M | 1.68 M | 1.68 M | 1.68 M | 934 K | 934 K | 934 K | 934 K | 996 K | 996 K | 996 K | 996 K | 645 K | 645 K | 645 K | 645 K | 682 K | 682 K | 682 K | 682 K | 1.23 M | - | - | - | - | - | - | - |
Accounts Receivables |
4.13 M | 1.05 M | 1.83 M | 1.54 M | 2.83 M | 13.5 M | 38.5 M | 10.2 M | - | 13.8 M | 8.68 M | 7.31 M | 10.3 M | 6.94 M | 5.52 M | 5.52 M | 5.52 M | 5.52 M | - | - | - | 500 K | 500 K | 500 K | 500 K | 500 K | - | - | - | - | - | - | - | - | - | 846 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency